Skip to content

Alto Neuroscience ANRO Accrued Manufacturing Costs

Accrued Manufacturing Costs at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
IAR
Integra LifeSciencesIART
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
Stryker logo
StrykerSYK
Lantheus Holdings logo
Lantheus HoldingsLNTH

Other financials

Income statement

See full
Operating income-$27.1M-73.1%
Net income-$26.2M-73.0%
EPS (diluted)-$0.80-42.9%

Balance sheet

See full
Cash & equivalents$264.3M+63.9%
Total debt$20.9M-17.2%
Total equity$243.4M+75.0%
Total assets$276.3M+60.7%

Cash flow

See full
Operating cash flow-$27.1M-63.6%
CapEx$556.0K+2,217%
Free cash flow-$27.6M-66.7%

Valuation

See full
Market cap$887.88M+1,358%
Enterprise value$644.49M-958%

Returns & leverage

See full
Return on equity-38.9%+0.9pp
Debt / equity0.1×-0.1×
Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's accrued manufacturing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Neuroscience's accrued manufacturing costs?
Alto Neuroscience (ANRO) reported accrued manufacturing costs of $2M in Q1 2026.
How has Alto Neuroscience's accrued manufacturing costs changed year-over-year?
Alto Neuroscience's accrued manufacturing costs decreased by 1.8% year-over-year, from $2.04M to $2M.
What is the long-term trend for Alto Neuroscience's accrued manufacturing costs?
Over 2 years (2023 to 2025), Alto Neuroscience's accrued manufacturing costs has grown at a 206.6% compound annual growth rate (CAGR), from $518K to $4.87M.